At the technical level, we worked on defining the main needs to optimize, adapt and validate our delivery systems. We decided to first focus the use of our technologies to deploy gastrointestinal plastic stents and to work, in the future, on developing delivery systems for ureteral stents and for the placement of a single stent. At the commercial level, we searched and identified many potential users, studied the different markets, compare our innovative devices with main competitors and describe EndoGI clinical validators, industrial partners and distributors. Besides, we proposed our commercial strategy, described key regulatory issues and requirements, and completed an FTO study. Financially, we estimated the budget to reach commercialization and make financial projections after market launch.